Arrowstreet Capital, Limited Partnership / LLY
Arrowstreet Capital, Limited Partnership’s Eli Lilly & Co Position
Does Arrowstreet Capital, Limited Partnership own Eli Lilly & Co (LLY)? Yes — 282.8K shares worth $260M (+0.14% of its 13F portfolio) as of Q1 2026, up from 167.7K shares the prior filed quarter.
Position Value
$260M
Q1 2026
Shares
282.8K
% of Portfolio
+0.14%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 282.8K | $260M | +0.14% |
| Q4 2025 | 167.7K | $180M | +0.11% |
| Q3 2025 | 100.4K | $77M | +0.05% |
| Q1 2025 | 41.4K | $34M | +0.03% |
| Q4 2024 | 14.8K | $11M | +0.01% |
| Q3 2024 | 1.63M | $1.4B | +1.23% |
| Q2 2024 | 1.61M | $1M | +1.28% |
| Q1 2024 | 1.17M | $909,378 | +0.84% |
| Q4 2023 | 939.7K | $547,753 | +0.57% |
| Q3 2023 | 1.47M | $790,468 | +0.96% |
| Q2 2023 | 1.38M | $647,888 | +0.79% |
| Q1 2023 | 1.45M | $496,987 | +0.64% |
| Q4 2022 | 1.93M | $707,248 | +0.99% |
| Q3 2022 | 2.48M | $803M | +1.18% |
| Q2 2022 | 3.57M | $1.2B | +1.64% |
| Q1 2022 | 3.31M | $948M | +1.18% |
| Q4 2021 | 2.14M | $591M | +0.72% |
| Q3 2021 | 1.05M | $244M | +0.31% |
| Q2 2021 | 65.5K | $15M | +0.02% |
| Q1 2021 | 410.8K | $77M | +0.10% |
| Q4 2020 | 842.5K | $142M | +0.20% |
| Q3 2020 | 1.24M | $184M | +0.29% |
| Q2 2020 | 899.9K | $148M | +0.27% |
| Q1 2020 | 226.5K | $31M | +0.09% |
| Q4 2019 | 117.4K | $15M | +0.04% |
| Q3 2019 | 1.19M | $133M | +0.31% |
| Q2 2019 | 1.40M | $156M | +0.35% |
| Q1 2019 | 627.5K | $81M | +0.19% |
| Q4 2018 | 2.26M | $262M | +0.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Arrowstreet Capital, Limited Partnership’s full portfolio or all institutional holders of LLY.